Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
CARISMA Therapeutics appoints Richard Morris CFO
CARISMA Therapeutics announced that Richard Morris had been appointed chief financial officer.
2021
CARISMA Therapeutics completes $47 million Series B financing
CARISMA Therapeutics completed a Series B equity financing that provided gross proceeds of $47 million.